MedPath

Evaluation of the Free α-hemoglobin Pool in the Red Blood Cells : Prognostic Marker and Severity Index in Thalassemic Syndromes

Not Applicable
Completed
Conditions
Thalassemic Syndromes
Registration Number
NCT02855957
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Brief Summary

Our project aims to assess and validate an innovative prognostic and diagnostic test in order to i) define a severity index of the β-thalassemia according to the free α-Hb pool for a better management of the patient; ii) differentiate the α-thalassemia and β-thalassemia and iii) follow the evolution of this pool in response to treatment of patients. In the future, this prognostic test based on the measurement of free α-Hb pool may be suitable for routine laboratory practice. To carry out this project, cohort of 85 thalassemic patients and a group of 50 healthy volunteers have been recruited.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
135
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Correlation between the pool of free α-Hb and genotype α and β -globin of the patient and if necessary with the genotype AHSP geneDay 1
Secondary Outcome Measures
NameTimeMethod
Correlation between the pool of free α-Hb and Mean Cell VolumeDay 1
Correlation between the pool of free α-Hb and percent of reticulocytesDay 1
Correlation between the pool of free α-Hb and Hb valueDay 1
Correlation between the pool of free α-Hb and fetal HbDay 1
Correlation between the pool of free α-Hb and erythrocyte enzymesDay 1
Correlation between the pool of free α-Hb and Mean Corpuscular HbDay 1

Trial Locations

Locations (1)

Henri Mondor Hospital

🇫🇷

Creteil, France

Henri Mondor Hospital
🇫🇷Creteil, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.